SkyTech Orion Global Corp. (CTGL), Operating Under Citrine Global Corp., Positioned Ahead of Market as Global Demand Accelerates for Western, Scalable Small-Drone Solutions
Washington, D.C./Tel Aviv, Dec. 12, 2025 (GLOBE NEWSWIRE) -- SkyTech Orion Global…
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citis 2025 Global Healthcare Conference in December
November 21, 2025 16:30 ET Â | Source: Teva Pharmaceutical Industries Ltd TEL…
Miggo Security Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Advancing Application Security Leadership
The company is redefining application security and AI Runtime Protection through its…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Wi-Charge Adds CMO and VP of People to Executive Team Following Series C Funding
Strategic Hires Underscore Momentum as Company Expands Global Commercialization of Long-Range Wireless…
Radware Schedules Conference Call for Its Second Quarter 2025 Earnings
TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR),…
LightSolver and HLRS Present Joint Research on Optical Computingat ISC High Performance 2025
TEL AVIV, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventors of…
Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study
TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET  | Source: ImPact Biotech – Previously inoperable…
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term…